Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
Frontiers in Public Health
|
May 13, 2025
Distribution characteristics of aerosol microorganisms in bronchoscopy room and the risk assessment of nosocomial infection
Wen Zhu, Yuehua Xu, Ting Chen, et al.
Discover Oncology
|
January 22, 2026
Chemotherapy combined with tislelizumab for a male patient with primary pulmonary choriocarcinoma: a case report and literature review
Xue Pan, Yongjian Pei, Ting Chen, et al.
Translational Cancer Research
|
November 14, 2025
LINC01314 suppresses proliferation and invasion via epithelial-to-mesenchymal transition regulation in lung adenocarcinoma
Wen Zhu, Xue Pan, Anyuan Zhong, et al.
Oncotargets and Therapy
|
December 15, 2015
Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis
Anyuan Zhong, Yufei Xing, Xue Pan, et al.
Nutrients
|
December 17, 2016
Abdominal Obesity and Lung Cancer Risk: Systematic Review and Meta-Analysis of Prospective Studies
Khemayanto Hidayat, Xuan Du, Guochong Chen, et al.
Frontiers in Pharmacology
|
November 8, 2021
TPD52L2 Is a Prognostic Biomarker and Correlated With Immune Infiltration in Lung Adenocarcinoma
Anyuan Zhong, Ting Chen, Tong Zhou, et al.
Frontiers in Immunology
|
November 8, 2021
FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer
Anyuan Zhong, Ting Chen, Yufei Xing, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 21, 2026
Targeting STAT3 by SH-4-54 suppresses the occurrence and inactivates oxidative phosphorylation in small-cell lung cancer via the SRC signaling
Chen Chen, Hang Hu, Zhongxiang Liu, et al.
The Journal of International Medical Research
|
February 9, 2026
Tuberous sclerosis complex with multisystem involvement: A case report
Haoran Chen, Minhua Shi, Yong Yu, et al.
Discover Oncology
|
April 2, 2026
PHC2 as a novel predictive biomarker and therapeutic target for cisplatin resistance in lung adenocarcinoma
Xue Pan, Xuejiao Sun, Yufei Xing, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
Frontiers in Public Health
|
May 13, 2025
Distribution characteristics of aerosol microorganisms in bronchoscopy room and the risk assessment of nosocomial infection
Wen Zhu, Yuehua Xu, Ting Chen, et al.
Discover Oncology
|
January 22, 2026
Chemotherapy combined with tislelizumab for a male patient with primary pulmonary choriocarcinoma: a case report and literature review
Xue Pan, Yongjian Pei, Ting Chen, et al.
Translational Cancer Research
|
November 14, 2025
LINC01314 suppresses proliferation and invasion via epithelial-to-mesenchymal transition regulation in lung adenocarcinoma
Wen Zhu, Xue Pan, Anyuan Zhong, et al.
Oncotargets and Therapy
|
December 15, 2015
Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis
Anyuan Zhong, Yufei Xing, Xue Pan, et al.
Nutrients
|
December 17, 2016
Abdominal Obesity and Lung Cancer Risk: Systematic Review and Meta-Analysis of Prospective Studies
Khemayanto Hidayat, Xuan Du, Guochong Chen, et al.
Frontiers in Pharmacology
|
November 8, 2021
TPD52L2 Is a Prognostic Biomarker and Correlated With Immune Infiltration in Lung Adenocarcinoma
Anyuan Zhong, Ting Chen, Tong Zhou, et al.
Frontiers in Immunology
|
November 8, 2021
FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer
Anyuan Zhong, Ting Chen, Yufei Xing, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 21, 2026
Targeting STAT3 by SH-4-54 suppresses the occurrence and inactivates oxidative phosphorylation in small-cell lung cancer via the SRC signaling
Chen Chen, Hang Hu, Zhongxiang Liu, et al.
The Journal of International Medical Research
|
February 9, 2026
Tuberous sclerosis complex with multisystem involvement: A case report
Haoran Chen, Minhua Shi, Yong Yu, et al.
Discover Oncology
|
April 2, 2026
PHC2 as a novel predictive biomarker and therapeutic target for cisplatin resistance in lung adenocarcinoma
Xue Pan, Xuejiao Sun, Yufei Xing, et al.
Page
of 6